Status:
COMPLETED
Combination of Continuous Femoral Block and Intravenous Parecoxib For Postoperative Analgesia After Total Knee Arthroplasty
Lead Sponsor:
Asklepieion Voulas General Hospital
Conditions:
POSTOPERATIVE ANALGESIA FOR TKA PARECOXIB/CFB
Eligibility:
All Genders
40-80 years
Phase:
PHASE2
PHASE3
Brief Summary
Combination of continuous femoral block with parEcoxib vs placebo. Investigation of morphine consumption, opioid sparing effects, VAS pain scores, haemodynamics, Anxierty scores, transfusion requireme...
Eligibility Criteria
Inclusion
- PATIENTS ASA I-II UNDERGOING TOTAL KNEE ATRTHROPLASTY
Exclusion
- Exclusion criteria for both groups included:
- Age younger than 40 years old or older than 80 years old
- ASA \> III
- Obesity (\>140 kg body weight)
- Allergy to local anesthetics
- History dependence on opioids
- Contraindications for subarachnoid anesthesia or femoral block (coagulopathy, local infection, pre-existing neurological problems, patient refusal)
- Contraindications to the administration of parecoxib
- Severe hepatic or renal disease (serum creatinine ≥ 1.7 mg/dl)
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2014
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT02185924
Start Date
January 1 2009
End Date
February 1 2014
Last Update
July 10 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anaesthesia Asklepeion Voulas General Hospital
Voula Athens, Greece, 16673